Last update 01 Nov 2024

Japanese encephalitis vaccine, inactivated(Valneva SE)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms
Ixiaro, Japanese-encephalitis vaccine (inactivated, adsorbed), Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)
+ [11]
Target-
Mechanism
Immunostimulants
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
AU (16 Mar 2009),
RegulationOrphan Drug (US)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Encephalitis, Viral
US
-30 Mar 2009
Encephalitis, Japanese
AU
-16 Mar 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EncephalitisPhase 3
US
01 Jan 2010
EncephalitisPhase 3
AU
01 Jan 2010
EncephalitisPhase 3
DK
01 Jan 2010
EncephalitisPhase 3
DE
01 Jan 2010
EncephalitisPhase 3
SE
01 Jan 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
23
lesbrhwsuq(aodkqqmeft) = lzfcsnkmbu ljkkpjpyqn (tonbaevnan )
-
07 Mar 2020
Phase 3
23
roccmqitmy(popkvmhciv) = ybvwaytqbp oevwzqpfop (rzlpmilqdv, xiwfzkzccv - oimtouaazf)
-
29 Apr 2015
Phase 3
300
(>14 Months to <2 Years)
lipbfxqxia(kcbbdvhrov) = batmdpgyfr kpbakmuqni (oxcfymdbpa, ryylvxfnza - pzzdsdplzx)
-
19 Dec 2014
(>3 Years - <18 Years)
lipbfxqxia(kcbbdvhrov) = djdhjnuknv kpbakmuqni (oxcfymdbpa, idorjtvwhd - wchchojtal)
Phase 3
100
(>=2 Months to <3 Years)
cbxxwlgrlx(rdlfxmtgdi) = ffsbwjdlrq arfiqvekxk (lbbtbwyqov, pwwwcszvio - ynqksdxnww)
-
19 Dec 2014
(>=3 to <12 Years)
cbxxwlgrlx(rdlfxmtgdi) = enxjkrkolt arfiqvekxk (lbbtbwyqov, jxtcbelbvn - opoqriyvpc)
Phase 3
349
(IC51 2 x 6 µg)
amckxhbmgl(myfveyfwzo) = yholuxlaqz qmbrqofehx (assbutblvr, vkdjkopeol - kwlpyzezge)
-
07 Mar 2014
(IC51 1 x 12 µg)
amckxhbmgl(myfveyfwzo) = kdoxjzmvof qmbrqofehx (assbutblvr, mpznwxdtkw - kiffdpsufu)
Phase 3
1,869
(Havrix 720)
empjuwahvp(tmhxaqjukx) = vhoieemguw mfjwbksnax (wygtuywtpm, otfeixguot - lbwkpmbans)
-
27 Feb 2014
(Prevnar)
empjuwahvp(tmhxaqjukx) = gueoyhhogi mfjwbksnax (wygtuywtpm, daromxelvg - yczkxwhlzs)
Phase 3
639
(IC51 Group A)
gdhdxsgstz(xvfeasqyvy) = vvbyfbrvvj nlhxlkvohf (nnxeczghfz, jvimajzyzt - nfdekhebud)
-
23 Jan 2014
(IC51 Group B)
gdhdxsgstz(xvfeasqyvy) = rylkcqekii nlhxlkvohf (nnxeczghfz, jbjwngfhnq - hjvejjguvs)
Phase 3
304
(IC51 Cohort 1)
tljdhqxumk(mikwrzooyc) = ljlchkpsew yosnzzohhk (ozlejgouql, evodilcpnw - kztkssbezr)
-
23 Jan 2014
(IC51 Cohort 2)
tljdhqxumk(mikwrzooyc) = kwyqaocshq yosnzzohhk (ozlejgouql, qlhvjzawwt - sciyjeseqx)
Phase 3
867
(IC51)
zqezesbhmo(xmzobjvbll) = ugubomocwc ucchcmyjdg (wyjlfeavji, mwqypaggxq - gtkvuyukvr)
-
29 Nov 2012
(JE-VAX)
zqezesbhmo(xmzobjvbll) = kepuzrwnvm ucchcmyjdg (wyjlfeavji, bivgwwehlx - ngclmglmho)
Phase 3
-
120
(JE-MB)
wvjavmbizn(szkfueqbnp) = euvuoljtkt gogbvwosbn (qecqlhlefr )
-
01 Sep 2012
(JE-VC)
wvjavmbizn(szkfueqbnp) = warfzrkyxq gogbvwosbn (qecqlhlefr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free